跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
!!Link opens in a new tab
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
吳 佳璋
教授
,
泌尿學科
主治醫師
,
衛生福利部雙和醫院
成員
,
臺北醫學大學泌尿腎臟研究中心
https://orcid.org/0000-0001-7476-0772
電子郵件
charleswjj
yahoo.com
tw
h-index
1107
引文
19
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2025
每年研究成果
概覽
指紋
網路
專案
(6)
研究成果
(92)
資料集
(1)
類似的個人檔案
(12)
指紋
查看啟用 Chia-Chang Wu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Transitional Cell Carcinoma
100%
Nephroureterectomy
69%
Bladder
31%
Recurrent Disease
30%
Overall Survival
30%
Upper Urinary Tract
28%
Urothelial Cancer
26%
Cancer Specific Survival
25%
Inguinal Hernia
23%
Cohort Analysis
22%
Prostate Cancer
22%
Disease Free Survival
21%
Urinary System
18%
Bladder Cancer
16%
Symptom
16%
Hernioplasty
15%
Neoplasm
15%
Recurrence Free Survival
14%
Uropathogenic Escherichia Coli
13%
Hydronephrosis
11%
Chronic Kidney Disease
11%
Malignant Neoplasm
11%
Treatment Response
10%
Cardiovascular Disease
10%
Hazard Ratio
10%
Herniorrhaphy
9%
Signal Transduction
9%
Upregulation
9%
Erectile Dysfunction
9%
Adjuvant Chemotherapy
9%
Ureter Tumor
9%
Oncology
9%
Infection
9%
Urinary Tract
9%
Hernia
9%
Prognostic Factor
9%
Meta-Analysis
9%
Prostate Cell
9%
Percutaneous Nephrolithotomy
9%
Methylation
9%
Clear Cell Renal Cell Carcinoma
9%
Randomized Clinical Trial
9%
Carcinogenicity
9%
Proportional Hazards Model
8%
Survival Rate
7%
Stent Placement
7%
Retrospective Study
7%
Postoperative Complication
7%
Metastatic Carcinoma
7%
Subgroup Analysis
7%
Pharmacology, Toxicology and Pharmaceutical Science
Transitional Cell Carcinoma
63%
Prostate Cancer
31%
Recurrent Disease
21%
Neoplasm
16%
Malignant Neoplasm
16%
Bladder Cancer
14%
Renal Cell Carcinoma
13%
Uropathogenic Escherichia Coli
13%
Cigarette Smoking
12%
Overall Survival
12%
Tumor Necrosis Factor
12%
Androgen
9%
Chemotherapy
9%
Interleukin 8
9%
Infection
9%
Castration Resistant Prostate Cancer
9%
Carcinogenicity
9%
Case-Control Study
8%
Arginine
8%
Prostate Specific Antigen
7%
Disease Exacerbation
7%
Disease
6%
Inflammation
5%
Enzalutamide
5%
Cardiovascular Disease
5%
Biochemistry, Genetics and Molecular Biology
Uropathogenic Escherichia Coli
13%
Tumor Necrosis Factor
11%
Genotyping
10%
Passive Smoking
10%
Signal Transduction
9%
Interleukin 8
9%
Gene Promoter
9%
Tumor Necrosis Factor Alpha
9%
Overall Survival
8%
Case-Control Study
7%
Cigarette Smoking
7%
Prostate-Specific Antigen
7%
Tumor Volume
6%
Cancer Specific Survival
6%
STAT1
6%
Disease Free Survival
6%
Survival Rate
5%
Gleason Score
5%
Promoter Region
5%
Enzalutamide
5%
Upregulation
5%
Anticancer
5%
